Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Operating Expenses: 2021-2025

Historic Operating Expenses for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to $1.1 billion.

  • Roivant Sciences' Operating Expenses fell 11.09% to $307.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 19.95%. This contributed to the annual value of $1.1 billion for FY2025, which is 29.26% up from last year.
  • As of FY2025, Roivant Sciences' Operating Expenses stood at $1.1 billion, which was up 29.26% from $884.1 million recorded in FY2024.
  • Roivant Sciences' 5-year Operating Expenses high stood at $1.4 billion for FY2022, and its period low was $884.1 million during FY2024.
  • In the last 3 years, Roivant Sciences' Operating Expenses had a median value of $938.3 million in 2023 and averaged $988.4 million.
  • In the last 5 years, Roivant Sciences' Operating Expenses crashed by 33.31% in 2023 and then climbed by 29.26% in 2025.
  • Over the past 5 years, Roivant Sciences' Operating Expenses (Yearly) stood at $1.1 billion in 2021, then grew by 28.52% to $1.4 billion in 2022, then plummeted by 33.31% to $938.3 million in 2023, then declined by 5.78% to $884.1 million in 2024, then climbed by 29.26% to $1.1 billion in 2025.